Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume $3.88 -0.28 (-6.73%) Closing price 04:00 PM EasternExtended Trading$3.84 -0.04 (-1.03%) As of 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics Short Interest DataIndaptus Therapeutics (INDP) has a short interest of 547,300 shares, representing 54.73% of the float (the number of shares available for trading by the public). This marks a 3,524.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 1.40 million shares to cover all short positions.Current Short Interest547,300 sharesPrevious Short Interest15,100 sharesChange Vs. Previous Month+3,524.50%Dollar Volume Sold Short$1.25 millionShort Interest Ratio4.7 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares1,110,000 sharesFloat Size1,000,000 sharesShort Percent of Float54.73%Today's Trading Volume169,998 sharesAverage Trading Volume1,401,817 sharesToday's Volume Vs. Average12% Short Selling Indaptus Therapeutics? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2025547,300 shares $1.25 million +3,524.5%54.7%4.7 $2.28 8/31/202515,100 shares $98.15 thousand -19.3%1.5%0.1 $6.50 8/15/202518,700 shares $143.52 thousand +64.0%2.1%0.1 $7.68 7/31/202511,400 shares $93.02 thousand -22.5%2.4%0 $8.16 7/15/202514,700 shares $179.19 thousand -50.8%3.1%0.1 $12.19 6/30/202529,900 shares $314.85 thousand -96.0%5.2%0.1 $10.53 6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32 5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34 5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42 4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50 3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55 3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81 2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84 2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80 1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91 1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87 12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84 12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00 11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02 11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11 10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17 10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27 9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24 9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51 8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65 8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67 7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04 7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20 6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12 6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47 5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37 5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26 11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20 10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38 8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08 4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61 4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75 2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93 4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 547,300 shares of INDP short. 54.73% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest ratio for Indaptus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INDP shares currently have a short interest ratio of 5.0. Learn More on Indaptus Therapeutics's short interest ratio. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 54.73% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a increase in short interest in September. As of September 15th, there was short interest totaling 547,300 shares, an increase of 3,524.5% from the previous total of 15,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 1,110,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 1,000,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 54.73% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Cellectar Biosciences, Inc. (2.84%), NextCure, Inc. (2.17%), Abpro Holdings Inc. (4.50%), Dogwood Therapeutics, Inc (2.06%), 180 Life Sciences Corp. (30.55%), Palisade Bio, Inc. (5.46%), Bullfrog AI Holdings Inc. (3.85%), Athira Pharma, Inc. (2.84%), BioVie Inc. (2.46%), Cyclacel Pharmaceuticals, Inc. (9.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies CLRB Short Interest Data NXTC Short Interest Data ABP Short Interest Data DWTX Short Interest Data ATNF Short Interest Data PALI Short Interest Data BFRG Short Interest Data ATHA Short Interest Data BIVI Short Interest Data CYCC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
